Categories: News

Delota Reports Third Quarter Revenue of $10.3 Million; $29.9 Million for the Nine Months Ended 2025 and Third Consecutive Quarter of Positive Adjusted EBITDA

Highlights:

Vaughan, Ontario–(Newsfile Corp. – January 2, 2025) – Delota Corp. (CSE: NIC) (FSE: S62) (“Delota” or the “Company“), a leading Canadian omni-channel retailer of nicotine vape and alternative tobacco products, is pleased to report it has filed its quarterly financial statements, management discussion and analysis, and associated certifications (collectively, the “Quarterly Filings“) for the three and nine months ended October 31, 2024. The Quarterly Filings may be accessed under the Company’s SEDAR+ profile at www.sedarplus.ca.

Cameron Wickham, CEO of Delota, commented, “Our third quarter financial results reflect consistent and stable growth having generated approximately $30 million in revenue for the nine months ended October 31, 2024 with three consecutive quarters of positive Adjusted EBITDA, totaling approximately $830,000 during this period. We remain on track of exceeding our run rate revenue target of $40 million for the full year. We are also looking to expedite our expansion plans in 2025 through strategic M&A opportunities that we have identified and are currently evaluating. Looking forward, we will continue to expand our footprint in Ontario, and strategically in major cities on the west coast. We will focus on growing our registered customer base and will look to unlock monetization opportunities from our platform. Our financial priorities include adding meaningful revenue to our topline through organic growth and M&A, as well as driving positive cash flow and margin expansion. Overall, I am very pleased with our third quarter results and look forward to providing further updates on our business.”

Financial Highlights:

  • Total revenue of $10,285,372 for the three months ended October 31, 2024 (“Q3 2025“) reflecting YoY growth of 27% as compared to the three months ended October 31, 2023.

    • 37% gross profit margin for Q3 2025

    • Positive Adjusted EBITDA of $380,110 for Q3 2025

  • Total revenue of $29,927,038 for the nine months ended October 31, 2024 (“Nine Months Ended 2025“), reflecting YoY growth of 25% as compared to the nine months ended October 31, 2023.

    •  39% gross profit margin for the Nine Months Ended 2025

    • Positive Adjusted EBITDA of $827,258 for the Nine Months Ended 2025

  • Segmented revenue for the Nine Months Ended 2025:

    • Vape – B2C: $23.5 million, B2B: $3.7 million

    • Cannabis – B2C: $2.7 million

Other Highlights:

  • On August 26, 2024, the Company opened an additional 180 Smoke Vape Store located at 499 Main Street South, Unit 60D, Shoppers World, Brampton, expanding 180 Smoke’s brick-and-mortar presence to 31 locations across Ontario.

  • On July 25, 2024, the Company opened a 180 Smoke Vape Store located at 70 Joseph Street, Parry Sound.

  • On April 11, 2024, the Company provided a corporate update on its significant growth and progress.

  • On April 2, 2024, the Company changed its stock symbol from “LOTA” to “NIC” on the Canadian Securities Exchange. The new stock symbol is intended to better align with its mission of becoming the largest national specialty retailer of nicotine vape and alternative tobacco products.

  • On February 5, 2024, the Company completed debt settlements in the amount of $215,000 with certain creditors of the Company to preserve cash for working capital through the issuance of 1,535,715 units of the Company at a price of $0.14 per unit.

Select Financial Information

The following selected financial information as at and for the nine months ended October 31, 2024 and the year ended January 31, 2024 are derived from the Company’s consolidated financial statements.

  Nine Months Ended
October 31, 2024
  Year Ended
January 31, 2024
 
$ $
Revenue 29,927,038 34,069,680
Net income (loss) 307,912 (1,992,576 )
Net earnings (loss) per share – basic and diluted 0.01 (0.07 )
   
Working capital (deficit) (790,654 ) (771,198 )
   
Total assets 15,005,151 13,735,729
Total non-current liabilities 5,968,005 6,565,672
Total liabilities 14,073,814 13,351,331
   
Capital stock 7,832,560 7,592,481
Warrant reserve 99,398 99,398
Contributed surplus 505,953 507,005
Accumulated deficit (7,506,574 ) (7,814,486 )
Shareholders’ equity (deficiency) 931,337 384,398

 

Adjusted EBITDA

The Company’s “Adjusted EBITDA” is a non-IFRS metric used by management that does not have any standardized meaning prescribed by IFRS and may not be fully comparable to similar measures presented by other companies. Management defines Adjusted EBITDA as the net income (loss) reported, before income taxes and other expense (income) items such as finance costs, finance income, gains and losses related to derivative liability valuations, and adjusted for share-based compensation, depreciation and amortization expenses, gains and losses related to the revaluations of its right-of-use assets and lease liabilities and foreign exchange differences.

The reconciliation of net income (loss) to Adjusted EBITDA is presented below.

Three Months Ended October 31, 2024 Three Months Ended October 31, 2023 Nine Months Ended October 31, 2024 Nine Months Ended October 31, 2023
$ $ $ $
Net income (loss) for the period – as reported 474,928 (545,828 ) 307,912 (1,033,001 )
                  
Depreciation and amortization 129,806 145,343 393,698 437,443
Interest and accretion expenses 203,876 31,214 611,721 93,302
Stock-based compensation 2,460 10,277 218,981
Fair value adjustment of derivative liabilities (417,743 ) (464,882 )
Deferred tax recovery (15,945 ) (15,945 ) (47,833 ) (47,833 )
Lease adjustments (2,592 ) 476,435 (5,184 ) 235,933
Foreign exchange loss 5,320 7,058 21,549 20,387
Adjusted EBITDA 380,110 98,277 827,258 (74,788 )

 

About Delota Corp.

Delota is the largest omni-channel specialty vape retailer in Ontario with a mission of becoming one of the largest national specialty retailers of nicotine vape and alternative tobacco products. The Company’s growth strategy includes aggressively growing its flagship brand, 180 Smoke Vape Store, by expanding its retail footprint organically in Ontario and select provinces across Canada, strengthening its national e-commerce platform, and through strategic M&A to accelerate growth and market consolidation. The Company is committed to expanding its nicotine product assortment, enhancing customer experience, and growing its registered customer base, which now exceeds 257,000 accounts.

Investors interested in learning more about Delota can visit www.delota.com.

For further information, please contact:

Delota Corp.

Julia Becker
Capital Markets
T: (604) 785-0850
E: ir@delota.com

Cameron Wickham
Executive Vice Chair and CEO
T: (905) 330-1602
E: info@delota.com

Cautionary Statements

This press release contains “forward-looking statements or information”. Forward-looking statements can be identified by words such as: anticipate, intend, plan, goal, seek, believe, project, estimate, expect, strategy, future, likely, may, should, will and similar references to future periods. Examples of forward-looking statements in this press release include statements made regarding information about future plans, expectations and objectives of the Company overall.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. The Company may not actually achieve its plans, projections, or expectations. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the adequacy of our cash flow and earnings, the availability of future financing and/or credit, developments and changes in laws and regulations, consumer sentiment towards the Company’s products, failure of counterparties to perform their contractual obligations, government regulations, competition, loss of key employees and consultants, and general economic, market or business conditions, the impact of technology and social changes on the products and industry, as well as those risk factors discussed or referred to in disclosure documents filed by the Company with the securities regulatory authorities in certain provinces of Canada and available at www.sedarplus.ca. Given these risks, uncertainties and assumptions, you should not place undue reliance on these forward-looking statements.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable securities laws, we undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235780

Staff

Recent Posts

AEON Biopharma, Inc. Announces Launch of Proposed Public Offering

IRVINE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”)…

8 hours ago

Oculis Publishes Notification of Major Changes in Voting Rights

ZUG, Switzerland, Jan. 04, 2025 (GLOBE NEWSWIRE) -- Attached is a Notification of Major Changes…

8 hours ago

ARCPOINT CLOSES SALE OF OWNERSHIP STAKE IN NON-CORE ASSET

Greenville, South Carolina , Jan. 03, 2025 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the…

8 hours ago

Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Carlsbad, CA, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc.  (Nasdaq: PALI) (“Palisade”, “Palisade…

8 hours ago

PharmaTher Announces Grant of Stock Options

TORONTO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB:…

8 hours ago

BriaCell Announces Proposed Effective Date of Share Consolidation

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq:…

8 hours ago